| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |